Cosentyx and Maxalt drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cosentyx (secukinumab) and Maxalt (rizatriptan benzoate). Common drug interactions include arthralgia among females and bulbar palsy among males.

The phase IV clinical study analyzes what interactions people have when they take Cosentyx and Maxalt. It is created by eHealthMe based on reports of 49 people who take the same drugs from the FDA, and is updated regularly.

What is Cosentyx?

Cosentyx has active ingredients of secukinumab. It is often used in psoriatic arthritis. eHealthMe is studying from 187,247 Cosentyx users. Check the latest studies of Cosentyx.

What is Maxalt?

Maxalt has active ingredients of rizatriptan benzoate. It is often used in migraine. eHealthMe is studying from 12,754 Maxalt users. Check the latest studies of Maxalt.

On Jul, 10, 2026

49 people who take Cosentyx and Maxalt together, and have interactions are studied.

What are the common drug interactions of Cosentyx and Maxalt, by gender? *:

female:

Arthralgia (joint pain)
Pain
Skin disorder (skin disease)
Psoriasis (immune-mediated disease that affects the skin)
Hot flush (sudden feelings of heat)
Inflammation
Rash morbilliform (a rash that looks like measles)
Rash pruritic (redness with itching)
Rectal haemorrhage (bleeding from anus)
Skin infection

male:

Bulbar palsy
Deafness
Upper respiratory tract inflammation
Weight decreased
Dyspepsia (indigestion)
Headache (pain in head)
Arthralgia (joint pain)
Diarrhoea
Fungal infection
Iritis (painful inflammation of the iris of the eye)

What are the common drug interactions of Cosentyx and Maxalt, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Arthralgia (joint pain)
Ear infection staphylococcal (ear infection by staphylococcal bacteria)
Pain
Pruritus (severe itching of the skin)
Rash
Therapeutic response decreased (less preventive response)

20-29:

n/a

30-39:

Influenza
Malaise (a feeling of general discomfort or uneasiness)
Nasopharyngitis (inflammation of the nasopharynx)
Diarrhoea
Fungal infection
Iritis (painful inflammation of the iris of the eye)
Oral pain
Pain
Pruritus (severe itching of the skin)
Pulmonary oedema (fluid accumulation in the lungs)

40-49:

Drug ineffective
Hypersensitivity
Psoriasis (immune-mediated disease that affects the skin)
Urticaria (rash of round, red welts on the skin that itch intensely)

50-59:

Pain
Psoriasis (immune-mediated disease that affects the skin)
Rash morbilliform (a rash that looks like measles)
Rash pruritic (redness with itching)
Rectal haemorrhage (bleeding from anus)
Skin disorder (skin disease)
Skin infection
Skin ulcer
Thermal burn (burn by heat)
Injection site bruising

60+:

Alopecia (absence of hair from areas of the body)
Arthralgia (joint pain)
Dyspepsia (indigestion)
Headache (pain in head)
Pruritus (severe itching of the skin)
Skin burning sensation
Stent placement

What are the existing conditions these people have? *

Psoriasis (immune-mediated disease that affects the skin): 23 people, 46.94%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 12 people, 24.49%
Immunodeficiency Common Variable: 9 people, 18.37%
Pain: 4 people, 8.16%
Juvenile Rheumatoid Arthritis (joint inflammation in children due to systemic disease): 3 people, 6.12%
Irritable Bowel Syndrome: 3 people, 6.12%
Cardiac Disorder: 3 people, 6.12%

* Approximation only. Some reports may have incomplete information.

Do you take Cosentyx and Maxalt?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously